4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-050757
Chief Scientific Officer bought 1,163 shares at $3.62 ($4,210)
From the SEC's structured data for this filing
Trades in this filing
Blouse Grant E. · Chief Scientific Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-09 | Purchase : show line 1 in the form | +1,163 | $3.62 | $4,210 | 2,917 | D |
| Open-market purchases · 1,163 sh · avg $3.62 · $4,210 | ||||||
Loading xslF345X03/doc4.xml…